Overview

This course is designed for healthcare professionals seeking a rigorous, evidence-based understanding of diabetes and cannabis. It combines contemporary science, clinical reasoning and international regulatory perspective.

Learning objectives

1) Understand the scientific basis for the potentialuse of cannabis in diabetes. 2) Interpret the current clinical evidence and its limitations. 3) Apply the evidence responsibly within your regulatory framework.

Why Take This Course?

Evidence-based knowledge — Understand what the current research actually shows about diabetes and medicinal cannabis. Clinical relevance — Connect scientific evidence with real-world clinical decision-making. Understand the endocannabinoid system — Learn the biological mechanisms that make cannabinoids relevant to diabetes. Evaluate the evidence critically — Recognise the strengths, limitations, and gaps in current research. Improve patient conversations — Gain the knowledge to discuss medicinal cannabis with patients in a clear, informed, and responsible way.

Curriculum

3 Chapters · 8 Lessons

    1. (Included in full purchase)

      Welcome to your course

    2. (Included in full purchase)

      Welcome Prof Kylie O'Brien

    3. (Included in full purchase)

      Your Video Settings

    1. (Included in full purchase)

      Learning Outcomes

    2. (Included in full purchase)

      Diabetes Part 1

    3. (Included in full purchase)

      Diabetes Part 2

    1. (Included in full purchase)

      End of Module Quiz

    2. (Included in full purchase)

      Certificate of Completion

Professor Kylie O'Brien

Director of Education PhD (Chin Med), MPH, BAppSc (Chin Med), BSc (Optometry), Grad Cert Tertiary Education Trained originally as an optometrist, after 15 years in clinical practice Kylie career-changed to Chinese medicine, developing a career as an academic and later holding senior administrative roles in universities and private education institutions. She entered the medicinal cannabis industry in 2018, where she became one of Australia's leading doctor educators, creating the first medicinal cannabis courses to receive Category 1 CPD approval from the Royal Australasian College of General Practitioners. She is actively involved in clinical research into medicinal cannabis, and has authored three books — one on integrative oncology and two on medicinal cannabis (mental health, women's health) — all published by Springer. She is an Adjunct Professor at Torrens University and an Adjunct Associate Professor at NICM Health Research Institute (Western Sydney University), a member of the Australian government's TEQSA Expert Panel, and sits on the Policy and Regulation Committee of the Federation of International Hemp Organisations (FIHO).